UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. Ma M, Zhang C, Cao R, Tang D, et al. Oncogene 2022;41:5199-5213.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma M, Zhang C, Cao R, Tang D, et al. UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. Oncogene 2022;41:5199-5213.
PMID: 36273042